Search Results - "EICKMEIER, Olaf"
-
1
Impact of CFTR Modulators on the Impaired Function of Phagocytes in Cystic Fibrosis Lung Disease
Published in International journal of molecular sciences (17-10-2022)“…Cystic fibrosis (CF), the most common genetically inherited disease in Caucasian populations, is a multi-systemic life-threatening autosomal recessive disorder…”
Get full text
Journal Article -
2
Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis
Published in PloS one (03-02-2017)“…Cystic fibrosis (CF) is an autosomal recessive genetic disorder that affects multiple organs, including the lungs, pancreas, liver and intestine. Mutations in…”
Get full text
Journal Article -
3
Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score
Published in Frontiers in pharmacology (03-06-2022)“…The novel and highly effective CFTR modulator combination of elexacaftor-tezacaftor-ivacaftor (ETI) has been shown to improve lung function and body weight in…”
Get full text
Journal Article -
4
Dual Role of microRNA-146a in Experimental Inflammation in Human Pulmonary Epithelial and Immune Cells and Expression in Inflammatory Lung Diseases
Published in International journal of molecular sciences (01-07-2024)“…microRNA (miR)-146a emerges as a promising post-transcriptional regulator in various inflammatory diseases with different roles for the two isoforms…”
Get full text
Journal Article -
5
Oxidative stress-driven pulmonary inflammation and fibrosis in a mouse model of human ataxia-telangiectasia
Published in Redox biology (01-04-2018)“…Lung failure is responsible for significant morbidity and is a frequent cause of death in ataxia-telangiectasia (A-T). Disturbance in the redox balance of…”
Get full text
Journal Article -
6
Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score
Published in Frontiers in pharmacology (03-05-2023)“…[This corrects the article DOI: 10.3389/fphar.2022.877118.]…”
Get full text
Journal Article -
7
Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire
Published in Frontiers in pharmacology (25-10-2023)“…Background: Elexacaftor–tezacaftor–ivacaftor (ETI) is a novel, highly effective CFTR modulator combination proven to enhance lung function and body weight in…”
Get full text
Journal Article -
8
Molecular Epidemiology of Mycobacterium abscessus Isolates Recovered from German Cystic Fibrosis Patients
Published in Microbiology spectrum (31-08-2022)“…Infections due to Mycobacterium abscessus are a major cause of mortality and morbidity in cystic fibrosis (CF) patients. Furthermore, M. abscessus has been…”
Get full text
Journal Article -
9
Immune response, diagnosis and treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis lung disease
Published in Current pharmaceutical design (01-06-2013)“…Patients with cystic fibrosis (CF) suffer from chronic infective lung disease, which determines morbidity and mortality. While bacteria, such as Pseudomonas…”
Get more information
Journal Article -
10
Patient Science: Citizen Science Involving Chronically Ill People as Co-Researchers
Published in Journal of participatory research methods (23-05-2022)“…Citizen science projects in health-related research usually follow a crowdsourcing approach where laypersons primarily have a supplying role in data…”
Get full text
Journal Article -
11
Transforming Growth Factor ß1 and Gap Junction Protein Alpha 4 Gene Heterogeneity in Relation to the Severity of Clinical Disease in Cystic Fibrosis
Published in Frontiers in bioscience (Landmark. Print) (19-07-2023)“…High TGFβ1-producing variants cause severe clinical disease in F508del homozygous patients. Lately, we showed that a single nucleotide polymorphism (SNP),…”
Get full text
Journal Article -
12
Impact of a Gap Junction Protein Alpha 4 Variant on Clinical Disease Phenotype in F508del Homozygous Patients With Cystic Fibrosis
Published in Frontiers in genetics (28-10-2020)“…Lung disease phenotype varies widely even in the (homozygous) genotype. Leukocyte-driven inflammation is important for pulmonary disease pathogenesis in cystic…”
Get full text
Journal Article -
13
Coil embolisation for massive haemoptysis in cystic fibrosis
Published in BMJ open respiratory research (12-08-2021)“…IntroductionMassive haemoptysis is a life-threatening event in advanced cystic fibrosis (CF) lung disease with bronchial artery embolisation (BAE) as standard…”
Get full text
Journal Article -
14
The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease
Published in PloS one (20-09-2011)“…The chitinase-like protein YKL-40 was found to be increased in patients with severe asthma and chronic obstructive pulmonary disease (COPD), two disease…”
Get full text
Journal Article -
15
Mannose-Binding Lectin (MBL) and Gap Junction Protein Alpha 4 (GJA4) Gene Heterogeneity in Relation to Severity of Clinical Disease in Cystic Fibrosis
Published in Frontiers in bioscience (Landmark. Print) (01-06-2022)“…BACKGROUNDRecently, we provided evidence that a single nucleotide polymorphism (SNP), rs41266431, on the gap junction protein alpha 4 (GJA4) gene, acts as a…”
Get full text
Journal Article -
16
Proinflammatory pattern in the lower airways of non-asthmatic obese adolescents
Published in Cytokine (Philadelphia, Pa.) (01-01-2024)“…Obesity is known to be a pro-inflammatory condition affecting multiple organs. Obesity as a systemic pro-inflammatory state, might be associated with bronchial…”
Get full text
Journal Article -
17
Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis
Published in Mycopathologia (1975) (01-02-2018)“…Cystic fibrosis (CF) is a chronic lethal multi-system condition; however, most of the morbidity and mortality is dependent on the status of the respiratory…”
Get full text
Journal Article -
18
Comparison of the Lung Clearance Index in Preschool Children With Primary Ciliary Dyskinesia and Cystic Fibrosis
Published in Chest (01-09-2022)“…Previous studies showed that the lung clearance index (LCI) determined by multiple-breath washout (MBW) is sensitive to detecting early lung disease in…”
Get full text
Journal Article -
19
Inflammation biomarkers in sputum for clinical trials in cystic fibrosis: current understanding and gaps in knowledge
Published in Journal of cystic fibrosis (01-07-2022)“…Sputum biomarkers hold promise as a direct measure of inflammation within the cystic fibrosis (CF) lung, but variability in study design and sampling…”
Get full text
Journal Article -
20
Clinical relevance of Aspergillus fumigatus sensitization in cystic fibrosis
Published in Clinical and experimental allergy (01-03-2020)“…Rationale The clinical relevance of sensitization to Aspergillus (A) fumigatus in cystic fibrosis (CF) is unclear. Some researchers propose that specific A…”
Get full text
Journal Article